ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Abbott Labs Cuts 700 Jobs Primarily In Manufacturing

By Peter Loftus Of DOW JONES NEWSWIRES Health-products maker Abbott Laboratories (ABT) has laid off about 700 workers, primarily in manufacturing operations, and plans to eliminate several hundred additional positions over the course of the year. The company attributed some of the layoffs to the impending mid-2012 expiration of Abbott's contract to supply the artery-opening stent Promus to Boston Scientific Corp. (BSX). Boston Scientific is shifting to a new version of Promus that it will manufacture internally. Orders for Promus have slowed ahead of the contract expiration, said Abbott spokesman Scott Stoffel. In addition, the layoffs affect some workers in Abbott's diagnostics and pharmaceutical manufacturing operations, Stoffel said. Abbott recorded unspecified costs associated with the work-force reduction in its fourth-quarter earnings report released earlier Wednesday. The costs were among restructuring, integration and other items that reduced Abbott's fourth-quarter earnings by about $276 million, or 18 cents a share. Abbott notified the affected workers Wednesday, including those at a stent manufacturing plant in Temecula, Calif. Abbott has about 91,000 employees worldwide. -Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
12/02/201607:00:00Boston Scientific Announces Agreement to Acquire Neovasc Advanced...
11/28/201618:25:00Nevro Files Lawsuit for Patent Infringement Against Boston Scientific...
11/23/201608:30:00Boston Scientific To Participate In Citi 2016 Global Healthcare...
11/22/201616:17:14Current Report Filing (8-k)
11/22/201608:36:00Boston Scientific Closes EndoChoice Acquisition
11/21/201607:00:00Boston Scientific Receives 2016 Shingo Prize for Operational...
11/16/201616:30:00Boston Scientific To Participate In Piper Jaffray 2016 Healthcare...
11/16/201613:34:00Boston Scientific Announces Positive Results Of HeartLogic™ H...
11/15/201606:30:00Boston Scientific Acquires Resectr™ Tissue Resection Device f...
11/04/201606:30:00Boston Scientific Announces Extension of the Cash Tender Offer...
11/03/201616:56:21Statement of Changes in Beneficial Ownership (4)
11/03/201616:51:34Statement of Changes in Beneficial Ownership (4)
11/03/201616:14:20Quarterly Report (10-q)
11/03/201606:30:00Boston Scientific Announces Acquisition Of The LumenR™ Tissue R...
11/02/201609:43:00Boston Scientific Announces Initial U.S. Commercial Performance...
11/02/201608:45:00The Shift of Medical Devices to a Home Setting
11/01/201616:11:05Statement of Changes in Beneficial Ownership (4)
11/01/201613:11:00Primary Endpoint from Study of Drug Eluting Coronary Stent in...
10/31/201609:00:00The Growth in Medical Device and Technology Markets
10/27/201616:42:09Statement of Changes in Beneficial Ownership (4)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US